Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis
- PMID: 23142380
- PMCID: PMC3538028
- DOI: 10.1016/j.ajpath.2012.09.009
Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis
Abstract
Pericytes have been identified as the major source of precursors of scar-producing myofibroblasts during kidney fibrosis. The underlying mechanisms triggering pericyte-myofibroblast transition are poorly understood. Transforming growth factor β-1 (TGF-β1) is well recognized as a pluripotent cytokine that drives organ fibrosis. We investigated the role of TGF-β1 in inducing profibrotic signaling from epithelial cells to activate pericyte-myofibroblast transition. Increased expression of TGF-β1 was detected predominantly in injured epithelium after unilateral ureteral obstruction, whereas downstream signaling from the TGF-β1 receptor increased in both injured epithelium and pericytes. In mice with ureteral obstruction that were treated with the pan anti-TGF-β antibody (1D11) or TGF-β receptor type I inhibitor (SB431542), kidney pericyte-myofibroblast transition was blunted. The consequence was marked attenuation of fibrosis. In addition, epithelial cell cycle G2/M arrest and production of profibrotic cytokines were both attenuated. Although TGF-β1 alone did not trigger pericyte proliferation in vitro, it robustly induced α smooth muscle actin (α-SMA). In cultured kidney epithelial cells, TGF-β1 stimulated G2/M arrest and production of profibrotic cytokines that had the capacity to stimulate proliferation and transition of pericytes to myofibroblasts. In conclusion, this study identified a novel link between injured epithelium and pericyte-myofibroblast transition through TGF-β1 during kidney fibrosis.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3538028/bin/gr1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3538028/bin/gr2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3538028/bin/gr3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3538028/bin/gr4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3538028/bin/gr5.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3538028/bin/gr6.gif)
![Figure 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3538028/bin/gr7.gif)
Similar articles
-
Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.Kidney Int. 2011 Dec;80(11):1170-81. doi: 10.1038/ki.2011.208. Epub 2011 Jun 29. Kidney Int. 2011. PMID: 21716259
-
Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.Stem Cell Res Ther. 2019 Mar 21;10(1):104. doi: 10.1186/s13287-019-1201-5. Stem Cell Res Ther. 2019. PMID: 30898157 Free PMC article.
-
Integrin β8 prevents pericyte-myofibroblast transition and renal fibrosis through inhibiting the TGF-β1/TGFBR1/Smad3 pathway in diabetic kidney disease.Transl Res. 2024 Mar;265:36-50. doi: 10.1016/j.trsl.2023.10.007. Epub 2023 Nov 4. Transl Res. 2024. PMID: 37931653
-
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.Kidney Int. 2011 May;79(9):944-56. doi: 10.1038/ki.2010.516. Epub 2011 Feb 9. Kidney Int. 2011. PMID: 21307839 Free PMC article. Review.
-
Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.J Formos Med Assoc. 2012 Nov;111(11):589-98. doi: 10.1016/j.jfma.2012.09.008. Epub 2012 Oct 24. J Formos Med Assoc. 2012. PMID: 23217594 Review.
Cited by
-
Exploring unconventional targets in myofibroblast transdifferentiation outside classical TGF- signaling in renal fibrosis.Front Physiol. 2024 May 14;15:1296504. doi: 10.3389/fphys.2024.1296504. eCollection 2024. Front Physiol. 2024. PMID: 38808357 Free PMC article. Review.
-
Multi-omics analysis of human tendon adhesion reveals that ACKR1-regulated macrophage migration is involved in regeneration.Bone Res. 2024 May 7;12(1):27. doi: 10.1038/s41413-024-00324-w. Bone Res. 2024. PMID: 38714649 Free PMC article.
-
Diabetes as a Pancreatic Microvascular Disease-A Pericytic Perspective.J Histochem Cytochem. 2024 Mar;72(3):131-148. doi: 10.1369/00221554241236535. Epub 2024 Mar 7. J Histochem Cytochem. 2024. PMID: 38454609 Review.
-
Mitochondrial Signaling, the Mechanisms of AKI-to-CKD Transition and Potential Treatment Targets.Int J Mol Sci. 2024 Jan 26;25(3):1518. doi: 10.3390/ijms25031518. Int J Mol Sci. 2024. PMID: 38338797 Free PMC article. Review.
-
Circulating Activin A, Kidney Fibrosis, and Adverse Events.Clin J Am Soc Nephrol. 2023 Nov 20;19(2):169-77. doi: 10.2215/CJN.0000000000000365. Online ahead of print. Clin J Am Soc Nephrol. 2023. PMID: 37983094
References
-
- Allt G., Lawrenson J.G. Pericytes: cell biology and pathology. Cells Tissues Organs. 2001;169:1–11. - PubMed
-
- Chang F.C., Chou Y.H., Chen Y.T., Lin S.L. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis. J Formos Med Assoc. 2012 http://dx.doi.org/10.1016/j.jfma.2012.09.008 DOI: - DOI - PubMed
-
- Kisseleva T., Cong M., Paik Y., Scholten D., Jiang C., Benner C., Iwaisako K., Moore-Morris T., Scott B., Tsukamoto H., Evans S.M., Dillmann W., Glass C.K., Brenner D.A. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A. 2012;109:9448–9453. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources